Myocardial perfusion imaging using technetium-99m radiopharmaceuticals.
Research and development in nuclear cardiology have made major contributions to the noninvasive approach for detection of coronary artery disease, to the assessment of disease extent and severity, and for prognostication of cardiac events. This article discusses the use of myocardial perfusion imaging and describes techniques for the evaluation of myocardial viability.
Kiat
H
H
Department of Imaging, Cedars-Sinai Medical Center, Los Angeles, California.
Berman
D S
DS
Maddahi
J
J
D003326:Coronary Circulation; D003327:Coronary Disease / Q000000981:diagnostic imaging; D003331:Coronary Vessels / Q000000981:diagnostic imaging*; D006801:Humans; D015609:Organotechnetium Compounds; D010091:Oximes; D011877:Radionuclide Imaging; D017256:Technetium Tc 99m Sestamibi
D015609:Organotechnetium Compounds; D010091:Oximes; D017256:Technetium Tc 99m Sestamibi; C060156:technetium Tc 99m teboroxime